These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

51 related items for PubMed ID: 204155

  • 21. [Correlation of hydrocortisone and corticosterone content in assessing the functional state of the adrenal cortex in varying forms of hypercorticism].
    Buniatian AF, Shekhter IM, Liashko KIa, Nosova AA, Udintsova TI.
    Probl Endokrinol (Mosk); 1977; 23(2):32-8. PubMed ID: 198763
    [Abstract] [Full Text] [Related]

  • 22. Adenocortical responsiveness to physiological amounts of 1-24 ACTH. I. Effect of prior administration of dexamethasone.
    Leclercq R, Copinschi G, Bruno OD.
    Horm Metab Res; 1972 May; 4(3):202-6. PubMed ID: 4339761
    [No Abstract] [Full Text] [Related]

  • 23. The effects of corticosteroids and ACTH on sensory systems.
    Henkin RI.
    Prog Brain Res; 1970 May; 32():270-94. PubMed ID: 4321526
    [No Abstract] [Full Text] [Related]

  • 24. Cortisol dynamics in the adrenal venous effluent.
    Spark RF, Kettyle WR, Eisenberg H.
    J Clin Endocrinol Metab; 1974 Aug; 39(2):305-10. PubMed ID: 4371157
    [No Abstract] [Full Text] [Related]

  • 25. [Cushing's syndrome and adrenal suppression by means of intranasal use of dexamethasone preparations].
    Reiner M, Galeazzi RL, Studer H.
    Schweiz Med Wochenschr; 1977 Dec 10; 107(49):1836-7. PubMed ID: 929148
    [Abstract] [Full Text] [Related]

  • 26. [Some indices of the adrenal cortex function in Itsenko-Cushing syndrome and adrenal cortex tumors].
    Marova EI.
    Probl Endokrinol (Mosk); 1968 Dec 10; 14(1):1-5. PubMed ID: 5736989
    [No Abstract] [Full Text] [Related]

  • 27. T lymphocytes and plasma inhibitory factor in ACTH-dependent Cushing's patients.
    Shohat B, Klein A, Kaufmann H, Blum I, Chowers I.
    Clin Immunol Immunopathol; 1979 Aug 10; 13(4):452-61. PubMed ID: 39699
    [No Abstract] [Full Text] [Related]

  • 28. Changes in the fine structure and function of a hormone-secreting adrenocortical tumour investigated in tissue culture.
    Szabó D, Gyévai A, Gláz E, Stark E, Péteri M, Alánt O.
    Virchows Arch A Pathol Anat Histol; 1975 Sep 18; 367(4):273-80. PubMed ID: 170731
    [Abstract] [Full Text] [Related]

  • 29. [Role of hormonal receptor abnormalities in the physiopathology of adrenocortical tumors].
    Lacroix A.
    Ann Endocrinol (Paris); 1995 Sep 18; 56(6):614-6. PubMed ID: 8787354
    [No Abstract] [Full Text] [Related]

  • 30. [Histological and enzyme histochemical studies on adrenocortical atrophy induced by hydrocortisone, dexamethasone and paramethasone].
    Sasano N, Ichinoe F, Hirano K.
    Nihon Naibunpi Gakkai Zasshi; 1966 Mar 20; 41(12):1432-7. PubMed ID: 4381691
    [No Abstract] [Full Text] [Related]

  • 31. Control of the adrenocortical cell cycle: interaction between FGF2 and ACTH.
    Armelin HA, Lotfi CF.
    Braz J Med Biol Res; 1999 Jul 20; 32(7):841-3. PubMed ID: 10454742
    [Abstract] [Full Text] [Related]

  • 32. Excess deoxycorticosterone secretion from adrenocortical carcinoma.
    Powell-Jackson JD, Calin A, Fraser R, Grahame R, Mason P, Missen GA, Powell-Jackson PR, Wilson A.
    Br Med J; 1974 Apr 06; 2(5909):32-3. PubMed ID: 4362452
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of growth dynamics and the relationship to the fluctuations in alkaline phosphatase in two strains of cells of HeLa S3 derivation.
    Brahmacupta P, Melnykovych G.
    In Vitro; 1980 May 06; 16(5):426-32. PubMed ID: 7390536
    [Abstract] [Full Text] [Related]

  • 34. Correlation of alkaline phosphatase staining of cortisol-producing adrenocortical tumors with dexamethasone suppression and ACTH stimulation.
    Aiba M.
    Acta Pathol Jpn; 1977 Nov 06; 27(6):877-91. PubMed ID: 204155
    [Abstract] [Full Text] [Related]

  • 35. ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site.
    Saez JM, Dazord A, Gallet D.
    J Clin Invest; 1975 Sep 06; 56(3):536-47. PubMed ID: 169292
    [Abstract] [Full Text] [Related]

  • 36. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
    Varga I, Jakab C, Szücs N, Patócs A, Tóth M, Kiss R, Gláz E, Rácz K.
    Horm Metab Res; 2003 Jul 06; 35(7):421-6. PubMed ID: 12931273
    [Abstract] [Full Text] [Related]

  • 37. Enzyme histo-cytochemical studies in human adrenocortical adenomas. [II] Cushing's syndrome.
    Murakoshi M, Osamura Y, Watanabe K, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1983 Jul 06; 8(3):293-300. PubMed ID: 6322390
    [Abstract] [Full Text] [Related]

  • 38. Evaluation and treatment of Cushing's syndrome.
    Nieman LK, Ilias I.
    Am J Med; 2005 Dec 06; 118(12):1340-6. PubMed ID: 16378774
    [Abstract] [Full Text] [Related]

  • 39. [Role of hormonal receptor abnormalities in the physiopathology of adrenocortical tumors].
    Lacroix A.
    Ann Endocrinol (Paris); 1995 Dec 06; 56(6):614-6. PubMed ID: 8787354
    [No Abstract] [Full Text] [Related]

  • 40. Correlation of alkaline phosphatase staining of cortisol-producing adrenocortical tumors with dexamethasone suppression and ACTH stimulation.
    Aiba M.
    Acta Pathol Jpn; 1977 Nov 06; 27(6):877-91. PubMed ID: 204155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.